GW 848687X, with the CAS number 612831-24-0, is a synthetic compound that belongs to the class of selective modulators of the androgen receptor (SARMs). It is primarily researched for its potential applications in treating conditions related to muscle wasting and osteoporosis. The compound exhibits a high affinity for androgen receptors, which allows it to selectively stimulate anabolic activity in muscle and bone tissues while minimizing androgenic effects in other tissues, such as the prostate. This selectivity is a key characteristic that distinguishes SARMs from traditional anabolic steroids. GW 848687X is typically studied in preclinical settings, and its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are of significant interest in the context of therapeutic development. However, as with many SARMs, the long-term safety and efficacy in humans remain to be fully established, and regulatory status may vary by region. Research continues to explore its potential benefits and risks in various medical applications.

GW 848687X

612831-24-0: GW 848687X, with the CAS number 612831-24-0, is a synthetic compound that belongs to the class of selective modulators of the androgen receptor (SARMs). It is primarily researched for its potential applications in treating conditions related to muscle wasting and osteoporosis. The compound exhibits a high affinity for androgen receptors, which allows it to selectively stimulate anabolic activity in muscle and bone tissues while minimizing androgenic effects in other tissues, such as the prostate. This selectivity is a key characteristic that distinguishes SARMs from traditional anabolic steroids. GW 848687X is typically studied in preclinical settings, and its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are of significant interest in the context of therapeutic development. However, as with many SARMs, the long-term safety and efficacy in humans remain to be fully established, and regulatory status may vary by region. Research continues to explore its potential benefits and risks in various medical applications.

GW848687X, a potent and selective prostaglandin EP1 receptor antagonist, is used for the treatment of inflammatory pain.

CAS 612831-24-0

GW 848687X

GW848687X

Ref: TM-T27517